StageZero Life Sciences Expands Cancer Care Reach with My One Medical Source Partnership

November 15, 2023 : StageZero Life Sciences, Ltd., a leading cancer diagnostics and treatment protocol provider, has announced a significant partnership with My One Medical Source (MOMS), a premier provider of medical testing services.
Nextgen i.i. Expands Global Presence, Secures Registration as an International Insurer in Puerto Rico

November 14, 2023 : Nextgen i.i., a leading provider of intelligent insurance solutions, has announced its registration as an international insurer in Puerto Rico.
Ultra-fine Medical Wire Market Surges Ahead, Driven by Minimally Invasive Surgeries and Aging Population

November 14, 2023 : The global ultra-fine medical wire market is poised for robust growth in the coming decade, fueled by the increasing demand for minimally invasive surgeries and the aging population.
Niterra Invests in Remote Patient Monitoring Startup Vivalink to Accelerate Development and Deployment of Innovative Healthcare Solutions

November 10, 2023 : Niterra, a global venture capital firm focused on innovative healthcare technologies, announced today that it has invested in Vivalink, a remote patient monitoring (RPM) startup.
FDA Approves New Obesity Drug Zepbound, First to Activate Two Key Hormone Receptors

November 10, 2023 : The Food and Drug Administration (FDA) has approved Eli Lilly’s Zepbound™ (tirzepatide) for chronic weight management, making it the first and only FDA-approved drug that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) hormone receptors.
Sodexo Appoints Molly Matthews as Chief Operating Officer for U.S. Healthcare & Seniors Divisions

November 7, 2023 : Sodexo, a global leader in services that enhance organizational performance, work environments, and employee well-being, has announced the appointment of Molly Matthews as Chief Operating Officer (COO) for its U.S. Healthcare and seniors divisions.
USFDA Approves Glenmark’s Generic Formulation for Schizophrenia Treatment

November 7, 2023 : Glenmark Pharmaceuticals, a leading global generics, and specialty pharmaceutical company, has received final approval from the United States Food and Drug Administration (USFDA) for its generic formulation of Chlorpromazine Hydrochloride Tablets USP, in the strengths of 10 mg, 25 mg, and 50 mg, 100 mg, and 200 mg.
Forging Strength: Unveiling the Best Exercises to Craft a Healthier, More Powerful You

In the world of business, where time is precious, and stress is abundant, maintaining a strong and healthy body can often take a back seat. But what if I told you that a strong body is not just a luxury but a critical asset for your journey?
Digitalization Drives Pharmacy Automation Market Growth, Revolutionizing Healthcare Systems

November 6, 2023 : The global pharmacy automation market is poised for significant growth, driven by the accelerating digitalization of healthcare systems and the increasing demand for efficient and error-free medication dispensing.
Instashield Expands into US Markets with MoU Signed with Montgomery County, Maryland

November 6, 2023 : Instashield, a medical device technology startup based in Hyderabad, India, has signed a Memorandum of Understanding (MoU) with Montgomery County, Maryland, USA, to facilitate its expansion into the US market.